World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02461628
Date of registration: 28/05/2015
Prospective Registration: Yes
Primary sponsor: Duke University
Public title: Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)
Scientific title: Innovative Partnership to Target Antimalarial Subsidies in the Retail Sector
Date of first enrolment: July 2015
Target sample size: 40340
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02461628
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Kenya
Contacts
Name:     Wendy O'Meara, PhD
Address: 
Telephone:
Email:
Affiliation:  Duke University
Key inclusion & exclusion criteria

INCLUSION CRITERIA

Intervention participation criteria:

- Client is older than 1 year

- Client has fever or history of fever or feeling unwell with a malaria-like illness
within the last 2 days

- Client or their parent/legal guardian (if under 18) consents to participate

Cross sectional survey participation criteria:

- Household representative in the intervention or control arm

- At least one member in the respondent's household with a history of fever or feeling
unwell with a malaria like illness within the last four weeks

- Respondent is older than 18 years

EXCLUSION CRITERIA

Intervention exclusion criteria:

- Client has signs of severe disease or other problem requiring immediate referral to a
health facility

- Client has already visited a health facility, taken or purchased antimalarials for the
current illness.

Cross sectional survey exclusion criteria:

• Households not in the intervention or control arms



Age minimum: 1 Year
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Malaria
Fever
Intervention(s)
Behavioral: Malaria RDT & conditional voucher for ACT from retail sector
Primary Outcome(s)
Number of Subjects With a Fever Who Receive a Malaria Test From Any Source [Time Frame: 6 months, 12 months, 18 months]
Secondary Outcome(s)
Number of Participants Using ACT Who Had a Positive Test [Time Frame: 6 months, 12 months, 18 months]
Number of Participants Using an ACT Who Did Not Have a Test [Time Frame: 6 months, 12 months, 18 months]
Number of Subjects Who Received a Correct Dose of AL (Artemether Lumefantrine) [Time Frame: 6 months, 12 months, 18 months]
Number of Subjects With Fever That Received Correct Treatment [Time Frame: 6 months, 12 months, 18 months]
Secondary ID(s)
Pro00063384
5R01AI110478
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Moi University
National Institute of Allergy and Infectious Diseases (NIAID)
Ethics review
Results
Results available: Yes
Date Posted: 29/10/2019
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02461628
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history